Kindred Bio Equine is one of the first veterinary biotechnology companies in the world and they have taken a revolutionary approach to delivering veterinary therapeutics in unmet and underserved areas. Through their understanding of similarities between human and equine diseases, they are creating breakthrough versions of effective human medications and biologics specifically for equines. In doing this, they believe they will be able to greatly increase the rate of success and bring the medications to market more quickly. This will in turn lead to a higher life quality for our equine companions and provide innovative treatment options for the veterinary community. KindredBio has a pipeline of cutting-edge drugs and biologics including treatments for fever in horses, equine gastric ulcers and metabolic syndrome in various stages of study.